152 related articles for article (PubMed ID: 27349376)
21. Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells.
Wu WR; Zhang R; Shi XD; Yi C; Xu LB; Liu C
Oncol Rep; 2016 Jul; 36(1):181-8. PubMed ID: 27221981
[TBL] [Abstract][Full Text] [Related]
22. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
[TBL] [Abstract][Full Text] [Related]
23. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.
Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B
Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577
[TBL] [Abstract][Full Text] [Related]
24. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
[TBL] [Abstract][Full Text] [Related]
25. lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal.
Zhu P; Wang Y; Huang G; Ye B; Liu B; Wu J; Du Y; He L; Fan Z
Nat Struct Mol Biol; 2016 Jul; 23(7):631-9. PubMed ID: 27239797
[TBL] [Abstract][Full Text] [Related]
26. "Fibrous nests" in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome.
Désert R; Mebarki S; Desille M; Sicard M; Lavergne E; Renaud S; Bergeat D; Sulpice L; Perret C; Turlin B; Clément B; Musso O
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):195-207. PubMed ID: 27545991
[TBL] [Abstract][Full Text] [Related]
27. snoRNA23 enhances the progression of hepatocellular carcinoma via regulation of the Wnt/?-catenin pathway.
Qiao S; Zhang X; Wu Z; Zhang L; Sun S
Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):155-160. PubMed ID: 34817323
[TBL] [Abstract][Full Text] [Related]
28. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
[TBL] [Abstract][Full Text] [Related]
29. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
[TBL] [Abstract][Full Text] [Related]
30. miR-381 Reverses Multidrug Resistance by Negative Regulation of the
Pu B; Yu X; Cao Y; Li Y; Tang L; Xia J
DNA Cell Biol; 2021 Dec; 40(12):1584-1596. PubMed ID: 34931867
[TBL] [Abstract][Full Text] [Related]
31. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
Gu W; Li X; Wang J
Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
[TBL] [Abstract][Full Text] [Related]
32. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
[TBL] [Abstract][Full Text] [Related]
33. DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling.
Liu Y; Zhou R; Yuan X; Han N; Zhou S; Xu H; Guo M; Yu S; Zhang C; Yin T; Wu K
Oncotarget; 2015 Apr; 6(11):8621-34. PubMed ID: 25940701
[TBL] [Abstract][Full Text] [Related]
34. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
[TBL] [Abstract][Full Text] [Related]
35. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
Ma L; Wang X; Jia T; Wei W; Chua MS; So S
Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miR-432 activates Wnt/β-catenin signaling and promotes human hepatocellular carcinoma proliferation.
Jiang N; Chen WJ; Zhang JW; Xu C; Zeng XC; Zhang T; Li Y; Wang GY
Oncotarget; 2015 Apr; 6(10):7866-79. PubMed ID: 25797263
[TBL] [Abstract][Full Text] [Related]
37. CXCL11 promotes self-renewal and tumorigenicity of α2δ1
Zhang Y; Zhao W; Li S; Lv M; Yang X; Li M; Zhang Z
Cancer Lett; 2019 May; 449():163-171. PubMed ID: 30771435
[TBL] [Abstract][Full Text] [Related]
38. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
[TBL] [Abstract][Full Text] [Related]
39. Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.
Sukowati CH; Anfuso B; Pascut D; Tiribelli C
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):723-5. PubMed ID: 25920931
[TBL] [Abstract][Full Text] [Related]
40. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.
Leung CO; Mak WN; Kai AK; Chan KS; Lee TK; Ng IO; Lo RC
Oncotarget; 2016 May; 7(20):29371-86. PubMed ID: 27105493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
